Devlyn Optical: Devlyn Optical Partners With Eyenuk to Offer Diabetic Retinopathy Screening With Pilot Set for Los Angeles Locations

LOS ANGELES-Eyenuk Inc. and Devlyn Optical, a spin-off of Grupo Devlyn, are planning to collaborate to pilot diabetic retinopathy (DR) screening services at Devlyn's convenient optical retail locations by leveraging Eyenuk's AI-enabled DR screening and telemedicine technologies, according to an announcement. Devlyn and Eyenuk will start the DR screening pilot in Los Angeles, a city where an estimated 11 percent of residents are living with diabetes. Both companies expect to expand their collaboration in the future through geographic expansion, screening for additional eye diseases (such as glaucoma and age-related macular degeneration), and utilizing novel eye screening technologies at mobile and kiosk-based locations, the announcement noted.